Scientists at the Scripps Research Institute (TSRI), the University of California (UC), Irvine and The University of Utah report that mice crippled by an autoimmune disease similar to multiple sclerosis (MS) regained the ability to walk and run after a team of researchers implanted human stem cells…
MS lesions
New research work from GlaxoSmithKline presented by Daren Ausin, PhD, at the American Academy of Neurology’s 66th Annual Meeting has implications for individuals with relapsinig-remitting multiple sclerosis. The presentation detailed a study that used GlaxoSmithKline’s ofatumumab in 231 patients with relapse-remitting multiple sclerosis. Ofatumumab is an anti-B-cell antibody, and it…
Recommended Posts
- Disrupted brain blood flow tied to poorer cognitive function in MS
- FDA grants priority review to ‘high-efficacy’ drug for 2 types of MS
- More than 3 million people living with MS globally, report shows
- Learning to listen as I wage a never-ending, silent battle with chronic pain
- Experimental therapy K-9 restores lost vision and mobility in MS mice